TrialFrontiers in immunology2021

Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine.

Susan Pederson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.